Cognition in first-episode psychosis

From phenomenology to intervention

Nicholas J K Breitborde, Madeline Meier

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Available research has clearly demonstrated that individuals with longstanding psychotic disorders have deficits in cognitive functioning that (i) have deleterious effects on their everyday functioning and (ii) can be partially ameliorated via available treatment options. Despite the fact that the cognitive deficits that accompany psychotic disorders are largely present by the time of the first-episode of psychosis, the nature of these associations in first-episode psychosis is less clear. Data are mixed with regard to a possible association between neurocognition and real-world functioning among individuals with first-episode psychosis, possibly due in part to methodological limitations of available studies. Although cognitive remediation has shown promise in ameliorating cognitive and functional deficits among individuals with longstanding psychotic disorder, these associations are not as robust for individuals with first-episode psychosis. With regard to pharmacological treatment, available data suggest that antipsychotic medications do not produce meaningful gains in cognitive functioning. Data in support of other pro-cognitive pharmacological agents are also limited. Ultimately, further research using methodologically sound approaches is needed to clarify the role of cognitive deficits in the disability that accompanies first-episode psychosis and to identify the most effective interventions with which to ameliorate these cognitive deficits.

Original languageEnglish (US)
Pages (from-to)306-318
Number of pages13
JournalCurrent Psychiatry Reviews
Volume12
Issue number4
DOIs
StatePublished - Dec 1 2016

Fingerprint

Psychotic Disorders
Cognition
Pharmacology
Research
Antipsychotic Agents

Keywords

  • Cognition
  • Cognitive enhancement
  • Cognitive remediation
  • First-episode psychosis
  • Pharmacology
  • Treatment

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Cognition in first-episode psychosis : From phenomenology to intervention. / Breitborde, Nicholas J K; Meier, Madeline.

In: Current Psychiatry Reviews, Vol. 12, No. 4, 01.12.2016, p. 306-318.

Research output: Contribution to journalReview article

@article{a89f66fd150e4f4a87949a0e2689c5e5,
title = "Cognition in first-episode psychosis: From phenomenology to intervention",
abstract = "Available research has clearly demonstrated that individuals with longstanding psychotic disorders have deficits in cognitive functioning that (i) have deleterious effects on their everyday functioning and (ii) can be partially ameliorated via available treatment options. Despite the fact that the cognitive deficits that accompany psychotic disorders are largely present by the time of the first-episode of psychosis, the nature of these associations in first-episode psychosis is less clear. Data are mixed with regard to a possible association between neurocognition and real-world functioning among individuals with first-episode psychosis, possibly due in part to methodological limitations of available studies. Although cognitive remediation has shown promise in ameliorating cognitive and functional deficits among individuals with longstanding psychotic disorder, these associations are not as robust for individuals with first-episode psychosis. With regard to pharmacological treatment, available data suggest that antipsychotic medications do not produce meaningful gains in cognitive functioning. Data in support of other pro-cognitive pharmacological agents are also limited. Ultimately, further research using methodologically sound approaches is needed to clarify the role of cognitive deficits in the disability that accompanies first-episode psychosis and to identify the most effective interventions with which to ameliorate these cognitive deficits.",
keywords = "Cognition, Cognitive enhancement, Cognitive remediation, First-episode psychosis, Pharmacology, Treatment",
author = "Breitborde, {Nicholas J K} and Madeline Meier",
year = "2016",
month = "12",
day = "1",
doi = "10.2174/1573400512666160927145737",
language = "English (US)",
volume = "12",
pages = "306--318",
journal = "Current Psychiatry Reviews",
issn = "1573-4005",
publisher = "Bentham Science Publishers B.V.",
number = "4",

}

TY - JOUR

T1 - Cognition in first-episode psychosis

T2 - From phenomenology to intervention

AU - Breitborde, Nicholas J K

AU - Meier, Madeline

PY - 2016/12/1

Y1 - 2016/12/1

N2 - Available research has clearly demonstrated that individuals with longstanding psychotic disorders have deficits in cognitive functioning that (i) have deleterious effects on their everyday functioning and (ii) can be partially ameliorated via available treatment options. Despite the fact that the cognitive deficits that accompany psychotic disorders are largely present by the time of the first-episode of psychosis, the nature of these associations in first-episode psychosis is less clear. Data are mixed with regard to a possible association between neurocognition and real-world functioning among individuals with first-episode psychosis, possibly due in part to methodological limitations of available studies. Although cognitive remediation has shown promise in ameliorating cognitive and functional deficits among individuals with longstanding psychotic disorder, these associations are not as robust for individuals with first-episode psychosis. With regard to pharmacological treatment, available data suggest that antipsychotic medications do not produce meaningful gains in cognitive functioning. Data in support of other pro-cognitive pharmacological agents are also limited. Ultimately, further research using methodologically sound approaches is needed to clarify the role of cognitive deficits in the disability that accompanies first-episode psychosis and to identify the most effective interventions with which to ameliorate these cognitive deficits.

AB - Available research has clearly demonstrated that individuals with longstanding psychotic disorders have deficits in cognitive functioning that (i) have deleterious effects on their everyday functioning and (ii) can be partially ameliorated via available treatment options. Despite the fact that the cognitive deficits that accompany psychotic disorders are largely present by the time of the first-episode of psychosis, the nature of these associations in first-episode psychosis is less clear. Data are mixed with regard to a possible association between neurocognition and real-world functioning among individuals with first-episode psychosis, possibly due in part to methodological limitations of available studies. Although cognitive remediation has shown promise in ameliorating cognitive and functional deficits among individuals with longstanding psychotic disorder, these associations are not as robust for individuals with first-episode psychosis. With regard to pharmacological treatment, available data suggest that antipsychotic medications do not produce meaningful gains in cognitive functioning. Data in support of other pro-cognitive pharmacological agents are also limited. Ultimately, further research using methodologically sound approaches is needed to clarify the role of cognitive deficits in the disability that accompanies first-episode psychosis and to identify the most effective interventions with which to ameliorate these cognitive deficits.

KW - Cognition

KW - Cognitive enhancement

KW - Cognitive remediation

KW - First-episode psychosis

KW - Pharmacology

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=85012065220&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85012065220&partnerID=8YFLogxK

U2 - 10.2174/1573400512666160927145737

DO - 10.2174/1573400512666160927145737

M3 - Review article

VL - 12

SP - 306

EP - 318

JO - Current Psychiatry Reviews

JF - Current Psychiatry Reviews

SN - 1573-4005

IS - 4

ER -